About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

VATS IN PATIENTS WITH ADVANCED OVARIAN MALIGNANCIES

NCT05840029·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Alexandria University

Age

20–80

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

FIGO stage III/IV ovarian cancer with or without pleural effusion

You may not be if

1. Previously treated ovarian disease.
2. Patient unfit for single lung ventilation.
3. Patients with previous lung surgery.
4. Patients with possible intrapleural adhesions.
5. Patients who had pulmonary resection.

The record

StatusUnknown

PhaseNo phase

Taking part68

StartedJun 2021

UpdatedMay 3, 2023

Conditions

Where1

Alexandria University
Alexandria, Egypt

Clareo Health | VATS IN PATIENTS WITH ADVANCED OVARIAN MALIGNANCIES